» Articles » PMID: 28109741

Eight Unexpected Cases of Vancomycin Associated Acute Kidney Injury with Contemporary Dosing

Overview
Publisher Elsevier
Date 2017 Jan 23
PMID 28109741
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Vancomycin is one of the most commonly utilized antibiotics in US hospitals. It remains the drug of choice for the treatment of serious infections caused by methicillin-resistant Staphylococcus aureus. For many of these deep-seated infections, guidelines recommend achieving troughs of 15-20 mg/L for treatment efficacy. At our institution we observed a number of cases of presumed vancomycin-induced acute tubular necrosis clinically diagnosed by the nephrology service. We report eight cases of presumed vancomycin-induced acute tubular necrosis, three of which required hemodialysis before resolution of nephrotoxicity. Only three of the eight patients received nephrotoxins prior to development of nephrotoxicity. All eight patients ultimately recovered renal function following discontinuation.

Citing Articles

Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Mahmoud A, Avedissian S, Al-Qamari A, Bohling T, Pham M, Scheetz M Clin Pharmacokinet. 2020; 59(12):1575-1587.

PMID: 32468446 PMC: 7704765. DOI: 10.1007/s40262-020-00902-1.


24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

ODonnell J, Rhodes N, Lodise T, Prozialeck W, Miglis C, Joshi M Antimicrob Agents Chemother. 2017; 61(11).

PMID: 28807910 PMC: 5655072. DOI: 10.1128/AAC.00416-17.

References
1.
Wunderink R, Niederman M, Kollef M, Shorr A, Kunkel M, Baruch A . Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. 2012; 54(5):621-9. DOI: 10.1093/cid/cir895. View

2.
Kullar R, Davis S, Taylor T, Kaye K, Rybak M . Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort. Pharmacotherapy. 2012; 32(3):195-201. DOI: 10.1002/j.1875-9114.2011.01017.x. View

3.
Oktem F, Koyuncu Arslan M, Ozguner F, Candir O, Yilmaz H, Ciris M . In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology. 2005; 215(3):227-33. DOI: 10.1016/j.tox.2005.07.009. View

4.
Gomes D, Smotherman C, Birch A, Dupree L, Della Vecchia B, Kraemer D . Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014; 34(7):662-9. DOI: 10.1002/phar.1428. View

5.
Vaidya V, Ozer J, Dieterle F, Collings F, Ramirez V, Troth S . Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010; 28(5):478-85. PMC: 2885849. DOI: 10.1038/nbt.1623. View